H. pylori Infection and Fertility
Based on current evidence, H. pylori infection is associated with reduced fertility in both men and women, and couples with unexplained infertility should be tested for H. pylori and treated if positive.
The Evidence for H. pylori's Impact on Fertility
The association between H. pylori and infertility is supported by multiple lines of evidence, though notably absent from major gastroenterology guidelines which focus primarily on peptic ulcer and gastric cancer prevention 1.
Male Fertility Effects
H. pylori infection, particularly with CagA-positive strains, significantly impairs male fertility parameters:
- Sperm motility is reduced by nearly 50% (18% vs 32% in CagA-positive vs negative patients) 2
- Sperm vitality drops substantially (35% vs 48%) 2
- Normal sperm morphology decreases (18% vs 22%) 2
- The fertility index is significantly reduced in CagA-positive infections 3
- Apoptosis and necrosis of sperm cells increase 3
The mechanism appears to involve both systemic inflammation (elevated TNF-alpha levels) and potential autoimmune phenomena through molecular mimicry between H. pylori proteins and human enzymes involved in sperm metabolism 2, 3.
Female Fertility Effects
In women, H. pylori impacts fertility through distinct mechanisms:
- Anti-H. pylori IgG antibodies in cervical mucus interfere with sperm penetration and progression 4
- There is a strong correlation (r=0.9275) between serum and cervical mucus antibody levels 4
- Women with unexplained infertility show higher H. pylori seropositivity rates (38.3% vs 20.2% in those with known infertility factors) 5
Overall Association
A meta-analysis of 1,902 patients demonstrated that H. pylori infection increases infertility risk by 45% (OR = 1.45,95% CI: 1.197-2.160) 6. This represents a statistically significant association with no publication bias detected.
Clinical Approach to Testing and Treatment
Who Should Be Tested
Test couples with unexplained infertility for H. pylori infection, particularly when:
- Standard fertility workup reveals no identifiable cause
- Male partner has abnormal semen parameters (reduced motility, vitality, or morphology)
- Female partner has cervical factor infertility
Testing Strategy
Use serum anti-H. pylori IgG antibody testing as the initial screening tool, as it:
- Correlates strongly with cervical mucus antibody levels in women 4
- Is non-invasive and readily available
- Can identify both active and past infection
For confirmation of active infection before treatment, consider:
- Urea breath test
- Stool antigen testing
- Endoscopic biopsy (if gastrointestinal symptoms present)
Treatment Approach
Treat all H. pylori-positive patients with unexplained infertility, following updated antimicrobial stewardship principles 1:
- Avoid empiric clarithromycin, metronidazole, and levofloxacin triple therapies due to increasing resistance 1
- Use bismuth-based quadruple therapy or other regimens effective against resistant strains
- Follow current ACG guidelines for treatment selection based on local resistance patterns 7
- Confirm eradication after treatment
Important Caveats
Pregnancy Considerations
While H. pylori is associated with pregnancy complications (preeclampsia, gestational diabetes, hyperemesis gravidarum, preterm birth) 8, 9, there is no recommendation for treating H. pylori during pregnancy according to consensus guidelines 10. Therefore:
- Test and treat BEFORE attempting conception
- Do not initiate H. pylori treatment in pregnant women for fertility purposes
- Focus on pre-conception eradication
Strength of Evidence
The fertility-H. pylori association is based primarily on observational studies and meta-analyses of case-control studies, not randomized controlled trials. However, the biological plausibility is strong given:
- Documented effects on sperm parameters
- Mechanical interference with sperm penetration via antibodies
- Systemic inflammatory effects
- Consistent associations across multiple studies
CagA Status Matters
CagA-positive strains have more pronounced effects on fertility 2, 3. If available, testing for CagA status may help risk-stratify patients, though all H. pylori-positive patients with infertility should be treated regardless.
Practical Algorithm
- Screen all couples with unexplained infertility for H. pylori using serology
- Confirm active infection with breath test or stool antigen if serology positive
- Treat with appropriate eradication therapy following resistance-guided protocols
- Verify eradication 4-6 weeks post-treatment
- Reassess fertility parameters 3-6 months after confirmed eradication
- Time conception attempts after confirmed eradication, not during treatment
This proactive approach aligns with the emerging paradigm of testing high-risk populations and addressing H. pylori before complications develop 1, extending the concept to reproductive health.